FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

31648011000036100: omalizumab (AU substance)

Status: current, Primitive. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
177397011000036116 omalizumab (AU substance) en Fully specified name Active Case sensitive Australian Medicines Terminology module
177398011000036115 omalizumab en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
omalizumab Is a medicinal substance true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
omalizumab has intended active ingredient True omalizumab Inferred relationship Some 1
omalizumab 150 mg injection, 150 mg vial (medicinal product unit of use) has intended active ingredient True omalizumab Inferred relationship Some 708169150
omalizumab 150 mg injection, 150 mg vial (medicinal product unit of use) has Australian BoSS True omalizumab Inferred relationship Some 708169150
Xolair (omalizumab 150 mg) powder for injection, 150 mg vial has intended active ingredient True omalizumab Inferred relationship Some 938422078
Xolair (omalizumab 150 mg) powder for injection, 150 mg vial has Australian BoSS True omalizumab Inferred relationship Some 938422078
Xolair 150 mg/mL injection, syringe has intended active ingredient True omalizumab Inferred relationship Some 1183718782
omalizumab 75 mg / 0.5 mL injection, 0.5 mL syringe (medicinal product unit of use) has intended active ingredient True omalizumab Inferred relationship Some 2012610754
omalizumab 75 mg / 0.5 mL injection, 0.5 mL syringe (medicinal product unit of use) has Australian BoSS True omalizumab Inferred relationship Some 2012610754
omalizumab 150 mg / 1 mL injection, 1 mL syringe (medicinal product unit of use) has intended active ingredient True omalizumab Inferred relationship Some 216374722
omalizumab 150 mg / 1 mL injection, 1 mL syringe (medicinal product unit of use) has Australian BoSS True omalizumab Inferred relationship Some 216374722
Xolair 75 mg/0.5 mL injection, 0.5 mL syringe has Australian BoSS True omalizumab Inferred relationship Some 1353575266
Xolair 150 mg/mL injection, syringe has Australian BoSS True omalizumab Inferred relationship Some 1183718782
Xolair 75 mg/0.5 mL injection, 0.5 mL syringe has intended active ingredient True omalizumab Inferred relationship Some 1353575266
omalizumab 75 mg injection, vial has Australian BoSS True omalizumab Inferred relationship Some 212603358
omalizumab 75 mg injection, vial has intended active ingredient True omalizumab Inferred relationship Some 212603358
Xolair (omalizumab 75 mg) powder for injection, 75 mg vial has intended active ingredient True omalizumab Inferred relationship Some 1351535202
Xolair (omalizumab 75 mg) powder for injection, 75 mg vial has Australian BoSS True omalizumab Inferred relationship Some 1351535202

This concept is not in any reference sets

Back to Start